Genetic polymorphisms associated with thrombotic disorders in the Japanese population

Fibrinolysis and Proteolysis

Volumn 14, Issue 2-3, 2000, Pages 155-164

  Murata, M ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN RECEPTOR; FIBRINOLYTIC FACTOR; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; HOMOCYSTEINE; INTEGRIN; PROTEIN C; PROTEIN S; PROTHROMBIN; VASOACTIVE AGENT;

ARTERIOSCLEROSIS; ARTERY DISEASE; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; THROMBOCYTE; THROMBOSIS;

EID: 0034049763     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1054/fipr.2000.0064     Document Type: Review

References (68)

1. Dahlback B, Carlsson M, Sevensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
2. Bertina RM, Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
3. Murata M, Kawano K, Matsubara Y, Ishikawa K, Watanabe G, Watanabe K, Ikeda Y. Genetic polymorphisms and risk of coronary artery disease. Semin Thromb Haemost 1998; 24: 245-250.
4. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480.
5. Di Minno G, Gradone E, Margaglione M. Clinical relevance of polymorphic markers of arterial thrombosis. Thromb Haemost 1997; 78: 462-466.
6. Gore I, Hirst AE, Tanaka K. Myocardial infarction and thrombosis. Arch Intern Med 1964; 323-330.
7. Nakamura M, Fujioka H, Nakano S. Venous thrombosis, pulmonary embolism. Thrombosis and Circulation 1996; 4: 47-52.
8. Kakkar W. The diagnosis of deep vein thrombosis using the 1251-fibrinogen test. Arch Surg 1972; 104: 152-159.
9. Hampson WGJ, Harris FC, Lucas HK, Roberts PH, McCall IW, Jackson PC, Powell NL, Staddon GE. Failure of low dose heparin to prevent deep vein thrombosis after hip-replacement arthroplasty. Lancet 1974; 5: 795-797.
10. Clark-Pearson DL, DeLong ER, Synan IS, Creasman WT. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. Obstet Gynecol 1984; 64: 689-694.
11. Zama T, Murata M, Ono F et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis and normal individuals. Int J Hematol 1996; 65: 71-78.
12. Isshiki I, Murata M, Watanabe R et al. Frequencies of prothrombin 20210 G/A mutation may be different among races - studies on Japanese populations with various forms of thrombotic disorders and healthy subjects. Blood Coagul Fibrinolysis 1998; 9: 105-106.
13. Legler TJ, Kohler M, Mayr WR, Panzer S, Ohto H and Fischer GF. Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligationbased typing. Transfusion 1996; 36: 426-431.
14. Murata M, Matsubara Y, Kawano K et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997; 96: 3281-3286.
15. Fuster V, Badimon L, Badimon JJ, and Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 356: 242-250.
16. del Zoppo GJ. The role of platelets in ischemic stroke. Neurology 1998; 51(3 Suppl 3): S9-14.
17. Harker LA. Therapeutic inhibition of platelet function in stroke. Cerebrovasc Dis 1998; 8 Suppl 5: 8-18.
18. Peterson DM, Stathopoulos NA, Giorgio TD, Hellumus JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet glycoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-628.
19. Ikeda Y, Handa M, Kawano K et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234-1240.
20. Santoro SA, Zutter MM. The α2β1 integrin: A collagen receptor on platelets and other cells. Thromb Haemost 1995; 74: 813.
21. Sixma JJ, Zanten GH, Huizinga EG, van der Plas RM, Verkley M, Wu YP, Gros P, de Groot PG. Platelet adhesion to collagen: an update. Thromb Haemost 1997; 78: 434.
22. Moroi M, Jung SM. Platelet receptor for collagen. Thromb Haemost 1997; 78: 439.
23. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994; 5: 97-119.
24. Clemetson KJ. Platelet GPIb-V-IX complex. Thromb Haemost 1997; 78: 266-270.
25. Wenger RH, Kieffer AN, Wicki N and Clemetson KJ. Structure of the human platelet membrane glycoprotein Ibα gene. Biochem Biophys Res Commun 1998; 156: 389-395.
26. Kuijpers RWAM, Faber NM, Cuypers HThM Ouwehand WH and von dem Borne AEGKr. NH2-terminal globular domain of human platelet glycoprotein Ibα has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992; 89: 381-384.
27. Murata M, Furihata K, Ishida F, Russell SR, Ware J and Ruggeri ZM. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood 1992; 79: 3086-3090.
28. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992; 267: 10055-10056.
29. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA. Kozak sequence polymorphism of the glycoprotein (GP) Ib alpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 1999; 94(1): 186-191.
30. Gonzalez-Conejero R, Lozano ML, Rivera J et al. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998; 92(8): 2771-1776.
31. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 1997; 28: 1392-1395.
32. Carter AM, Catto AJ, Bamford JM, Grant PJ. Platelet GPIIIa P1A1 and GPIb variable number of tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler Thromb Vasc Biol 1998; 18: 1124-1131.
33. Sonoda A, Murata M, Ito D et al. Association between platelet glycoprotein Ibα genotype and ischemic cerebrovascular disease. Stroke 2000; 31: 493-497.
34. Mazzucato M, Pradella P, De Angelis V, Stefan A, De Marco L. Frequency and functional relevance of genetic threonin145/methionin145 dimorphism in platelet glycoprotein Ibα in an Italian population. Transfusion 1996; 6: 891-894.
35. Li CQ, Garner SF, Davies J, Smethurst PA, Wardell MR, Ouwehand WH. Threonine-145/Methionine-145 variants of baculovirus produced recombinant ligand binding domain of GPIbα express HPA-2 epitopes and show equal binding of von Willebrand factor. Blood 2000; 95: 205-211.
36. Corral J, Lozano ML, Gonzalez-Conejero R et al. A common polymorphism flanking the ATG initiation codon of GPIbα does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 2000; 83: 23-28.
37. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Heredity variation in platelet integrin a2bl density is associated with two silent polymorphisms in the a2 gene coding sequence. Blood 1997; 89: 1939.
38. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, Kunicki TJ. Nucleotide polymorphism in the a2 gene define multiple alleles that are associated with differences in platelet a2b1 density. Blood 1998; 92: 1.
39. Reiner AP, Aramaki KM, Teramura G, Gaur L. Analysis of platelet glycoprotein Ia (alpha2 integrin) allele frequencies in three North American populations reveals genetic association between nucleotide 807C/T and amino acid 505 Glu/Lys (HPA-5) dimorphisms. Thromb Haemost 1998; 80: 449.
40. Carlsson LE, Santoso S, Spitzer C, Kessler C, Greinacher A. The alpha2 gene coding sequence T807/A873 of the platelet collagen receptor integrin alpha2betal might be a genetic risk factor for the development of stroke in younger patients. Blood 1999; 93: 3583.
41. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449.
42. Moshfegh K, Wuillemin WA, Redondo M et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: A case-control study. Lancet 1999; 353: 351.
43. Matsubara Y, Murata M, Maruyama T et al. Association between diabetic retinopathy and genetic variations in α2β1 Integrin, a platelet receptor for collagen. Blood 2000; 95: 1560-1564.
44. Weiss EJ, Bray PF, Tayback M et al. A polymorphism of platelet glycoprotein receptor as an inhierited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-1094.
45. Ridker PM Hennekens CH Schmitz C, Stampfer MJ and Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein Ilia and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997; 349: 385-388.
46. Feng D, Lindpaintner K, Larson D et al. Increased platelet aggregability associated with platelet GPIIIa P1A2 polymorphism. The Framingham offspring study. Arterioscler Thromb Vasc Biol 1999; 19: 1142-1147.
47. Bennet JS, Vilarire G, Catella-Lawson F, Rut AR, Fitzgerald G. The P1A1 alloantigen does not alter the affinity of GPIIb-IIIa for fibrinogen or RGD-containing peptides. Blood 90: 154a, 1997.
48. Cook GE, Bray PF, Hamlington J, Pham DM, GoldschmidtClermont PJ. P1A2 polymorphism and efficacy of aspirin. Lancet 1998; 351: 1353.
49. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995; 15: 96-104.
50. Poort, SR, Rosendaal FR, Restina PH and Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
51. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 90: 1747-1750.
52. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134.
53. Bernardi F, Marchetti G, Pinotti M et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996; 16:72-76.
54. Heywood DM, Mansfield MW and Grant PJ. Factor VII polymorphism, factor VII: C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus. Thromb Haemostas 1996; 75: 401-406.
55. Iacoviello L, Castelnuovo AD, Knijff P et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85.
56. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki M, Niho Y. A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998; 91:2010-2014.
57. Oguchi S, Ito D, Murata M et al. Genotype distribution of the 46C/T polymorphism of coagulation factor XII in the Japanese population: absence of its association with ischemic cerebrovascular disease. Thromb Haemost 2000; 83: 178-179.
58. Gordon EM, Donaldson VH, Saito H, Su E, Ratnoff OD. Reduced titer of Hageman factor (Factor XII) in Orientals. Ann Intern Med 1981; 95: 697-700.
59. Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP. Risk of coronary heart disease and activation of factor XII in middleaged men. Arterioscler Thromb Vasc Biol 1997; 17: 2103-2106.
60. Ishii K, Oguchi S, Murata M et al. Activated factor XII levels are dependent on factor XII46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects. Blood Coagul Fibrinolysis 2000; (in press).
61. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
62. Catto AJ, Kohler HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 1999; 93: 906-908.
63. Anwar R, Gallivan L, Edmonds SD, Markham AR Genotype/phenotype correlations for factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 1999; 93: 897-905.
64. Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promotor polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 1995; 74: 1032-1034.
65. Zama T, Murata M, Matsubara Y et al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphisms is associated with the increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 1997; 17: 3565-3569.
66. Hubacek JA, Pit'fha J, Skodava Z, Stanek V, Poledne R. C(-260)-T polymorphism in the promoter of the CD 14 monocyte receptor gene as the risk factor for myocardial infarction. Circulation 1999; 99: 3218-3220.
67. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD 14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999; 19: 932-938.
68. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, Fukuuchi Y. C242T polymorphism of NADPH oxidase p22 phox gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000; 31: 936-939.